Cargando…

Association between Parkinson's disease and proton pump inhibitors therapy in older people

OBJECTIVES: The study was to explore the association between Parkinson's disease and proton pump inhibitors use. METHODS: A population-based case-control study was conducted to analyze the 2000-2013 database of Taiwan National Health Insurance Program. In total, there were 4280 participants age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Shih-Wei, Liao, Kuan-Fu, Lin, Cheng-Li, Lin, Chih-Hsueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	China Medical University 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721474/ https://www.ncbi.nlm.nih.gov/pubmed/33854921 http://dx.doi.org/10.37796/2211-8039.1048

Ejemplares similares

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Herpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2017)

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan
por: Cheng, Kao-Chi, et al.
Publicado: (2017)

Spectrophotometric Determination of Certain Benzimidazole Proton Pump Inhibitors
por: Syed, A. A., et al.
Publicado: (2008)

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours
por: Korse, C M, et al.
Publicado: (2011)

Deprescribing in older people: helpful tools and proton pump inhibitors
Publicado: (2020)

Comparative Study of Proton Pump Inhibitors on Dexamethasone Plus Pylorus Ligation Induced Ulcer Model in Rats
por: Thippeswamy, A. H. M., et al.
Publicado: (2010)

Statins use and female lung cancer risk in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2012)

Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
por: Bödvarsdóttir, T. B., et al.
Publicado: (2010)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

No Association between Depression and Risk of Hepatocellular Carcinoma in Older People in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2013)

Use of thiazolidinediones and risk of hip fracture in old people in a case–control study in Taiwan
por: Lin, Hsien-Feng, et al.
Publicado: (2017)

Allopurinol use associated with increased risk of acute myocardial infarction in older people in a case–control study
por: Liao, Kuan-Fu, et al.
Publicado: (2019)

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors
por: Boxer, Michael
Publicado: (2020)

Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients
por: Delcher, Anne, et al.
Publicado: (2015)

Proton pump inhibitors and the risk of severe cognitive impairment: The role of posttraumatic stress disorder
por: Clouston, Sean A.P., et al.
Publicado: (2017)

Rebuilding trust in proton pump inhibitor therapy
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients
por: Zirk-Sadowski, Jan, et al.
Publicado: (2017)

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan
por: Chen, Huan-Lin, et al.
Publicado: (2023)

Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps
por: Chakrabarti, Anindita, et al.
Publicado: (2022)

Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2016)

Internal tremor in people with Parkinson’s Disease: Demographic characteristics and comorbid symptoms
por: Chahine, Lana M., et al.
Publicado: (2023)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Case-control study examining the association between hip fracture risk and statins therapy in old people
por: Cheng, Kao-Chi, et al.
Publicado: (2019)

Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use
por: Musuuza, Jackson S., et al.
Publicado: (2021)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Proton therapy and the European Particle Therapy Network: The past, present and future()
por: Weber, D.C., et al.
Publicado: (2020)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Association between Proton Pump Inhibitor Use and Parkinson’s Disease in a Korean Population
por: Kim, Ji-Hee, et al.
Publicado: (2022)

A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson's disease
por: Sharma, Neena K, et al.
Publicado: (2015)

Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action
por: Meinders, Marjan J., et al.
Publicado: (2022)

Empowered patient: A program to improve people with Parkinson’s communication with health care professionals
por: Zaman, Muhammed Shahriar, et al.
Publicado: (2022)

Prescribing Pattern of Proton Pump Inhibitors in Qatar Rehabilitation Institute: A Retrospective Study
por: Madi, Lama, et al.
Publicado: (2019)

Proton pump inhibitors and sensitization of cancer cells to radiation therapy
por: Hebert, Kassidy A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rokja4rnsjjs0dp09fsk2j02e